Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Announces Notification of FDA Action Date Extension for Probuphine

February 19, 2016

Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce FDA Advisory Committee Recommends Approval of Probuphine, First 6-Month Implant to Treat Opioid Addiction

January 12, 2016

Trading of Titan Pharmaceuticals Stock Halted Today

January 12, 2016

Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction

December 9, 2015

Titan Pharmaceuticals Adds ProNeura Implant for Hypothyroidism to Product Development Pipeline

November 16, 2015

Titan Pharmaceuticals Reports Third Quarter 2015 Financial Results

November 16, 2015

Titan Pharmaceuticals Schedules Conference Call to Review Third Quarter 2015 Financial Results

November 10, 2015

Titan Pharmaceuticals Announces Uplisting to NASDAQ

October 8, 2015

Titan Pharmaceuticals Provides Opinion of Counsel Covering Issuance and Resale of Shares Underlying Public Warrants

October 7, 2015

Titan Pharmaceuticals Announces FDA's Acceptance of Resubmission of New Drug Application for Probuphine

September 28, 2015

  • « Previous
  • 1...
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • ...24
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter